Live endometrial cancer updates

Live endometrial cancer news coverage of developments with the latest updates. Stay on top of latest endometrial cancer news stories and find out what just happened, what is going on with endometrial cancer. The latest real-time news updates and headlines on endometrial cancer
Women at elevated breast cancer risk may see mortality benefit from estrogen-blocking drugs
New Anti-tumor Drug TR128 Approved for Clinical Trial
UC Davis Health adopts low pressure surgery systemwide
HKUMed discovers glucose control may improve antitumour activity of γδ-T cells in diabetes
Having more babies lowers risk of endometrial cancer
New therapeutic strategy to improve treatment of aggressive endometrial cancer
Why immunotherapy works well for some cancer patients, but not others
Imjudo in combination with Imfinzi approved in US for patients with unresectable liver cancer
HSD3B1 gene research reveals association between genotype and endometrial cancer
Oral contraceptives and hormone therapy increase risk of stroke
Imfinzi plus chemotherapy significantly improved pathologic complete response in AEGEAN Phase III trial
CPTAC renews funding for proteogenomics research at Baylor
CHOP, PTEN Foundation Center of Excellence, Hosts PTEN Conference
Weight loss with bariatric surgery cuts risk of developing cancer and death from cancer
Imfinzi plus chemotherapy granted Priority Review in US for patients with locally advanced or metastatic biliary tract cancer based on TOPAZ-1 Phase
Things are not yet running smoothly
Tremelimumab accepted under Priority Review in US for patients with unresectable liver cancer
MD Anderson research highlights for April 13, 2022
Dual-Mode Endoscope Offers Unprecedented Insights into Uterine Health
Karen Lu honored by AACR for contributions to cancer research
SGO 2022 Special Edition
Drug combination shows effectiveness in patients with recurrent ER-positive endometrial cancer
Drug combination reveals effectiveness in patients with recurrent ER-positive endometrial cancer
When and how mutant clones expand in normal endometrium
Anti-Müllerian hormone may contribute to infertility in polycystic ovary syndrome
Visualizing Invisible: New Fluorescent DNA Label Reveals Nanoscopic Cancer Features
Studies reinforce link using bariatric surgery to reduce obesity-associated breast cancer
Weight loss points to better surgical outcomes for women with obesity and uterine cancer
Identification of gene networks involved in uterine cancer could lead to better treatment options
Does coffee help protect against endometrial cancer?
Bariatric Surgery and Complicated Reality of Weight Loss
Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer
Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive
Prime time: First therapeutic clinical trial of C’Dots underway
Study offers hope of new treatments for endometrial cancer
Simple, cheap urine test can detect urothelial cancers in Lynch Syndrome patients
QIMR Berghofer scientist elected Fellow of Australian Academy of Health and Medical Sciences
Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial
Contraceptive pill can reduce type 2 diabetes risk in women with polycystic ovary syndrome, reveals study
Connecting genes to diseases through proteins
AACR Cancer Progress Report highlights how discovery science is driving clinical breakthroughs
MD Anderson research highlights for September 22, 2021
Women’s Health Multidisciplinary Consortium Launches a “Hot Topics” Seminar Series
Imfinzi approved in China for treatment of extensive-stage small cell lung cancer
Screening often misses endometrial cancer in Black women
Women need individualised help with weight after endometrial cancer
Anders Sejr Hansen awarded prestigious Pew-Stewart Grant for Cancer Research
Hansen awarded prestigious Pew-Stewart Grant for Cancer Research